A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21
Condition: Malaria, Plasmodium Falciparum Intervention: Biological: Matrix-M with RH5.2 VLP and/or R21 Sponsors: University of Oxford; European and Developing Countries Clinical Trials Partnership (EDCTP); Medical Research Council Unit The Gambia at the LSHTM (MRCG) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2022 Category: Research Source Type: clinical trials
Safety and Immunogenicity of Pvs25-IMX313/Matrix-M1 Vaccine
Condition: Malaria, Vivax Intervention: Biological: Pvs25-IMX313/Matrix-M1 Sponsor: University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2022 Category: Research Source Type: clinical trials